ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.700
-0.040 (-2.30%)
At close: Sep 18, 2026, 4:00 PM EDT
1.690
-0.010 (-0.59%)
After-hours: Sep 18, 2026, 7:30 PM EDT
ALX Oncology Holdings Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, ALX Oncology Holdings stock has a consensus rating of "Strong Buy" and an average price target of $4.60. The average 1-year stock price forecast is 170.59% higher than the current stock price, while the lowest is $4.00 (+135.29%) and the highest is $6.00 (+252.94%).
Price Target: $4.60 (+170.59%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 17, 2026.
Analyst Ratings
The average analyst rating for ALX Oncology Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $4 | Buy | Maintains | $4 | +135.29% | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +135.29% | Aug 10, 2026 |
| LifeSci Capital | LifeSci Capital | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 7, 2026 |
| UBS | UBS | Buy Maintains $6 | Buy | Maintains | $6 | +252.94% | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.65
from -1.66
EPS Next Year
-0.54
from -0.65
EPS and Forward PE are based on non-GAAP adjusted numbers.